Home
>
National Drug Code (NDC)
>
Methotrexate
Methotrexate - 55390-143-01 - (Methotrexate)
Drug Information of Methotrexate
| Product NDC: | 55390-143 |
| Proprietary Name: | Methotrexate |
| Non Proprietary Name: | Methotrexate |
| Active Ingredient(s): | 1 g/20mL & nbsp; Methotrexate |
| Administration Route(s): | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Methotrexate
| Product NDC: | 55390-143 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040632 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20050906 |
Package Information of Methotrexate
| Package NDC: | 55390-143-01 |
| Package Description: | 1 VIAL in 1 BOX (55390-143-01) > 20 mL in 1 VIAL |
NDC Information of Methotrexate
| NDC Code | 55390-143-01 |
| Proprietary Name | Methotrexate |
| Package Description | 1 VIAL in 1 BOX (55390-143-01) > 20 mL in 1 VIAL |
| Product NDC | 55390-143 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Methotrexate |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
| Start Marketing Date | 20050906 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | METHOTREXATE |
| Strength Number | 1 |
| Strength Unit | g/20mL |
| Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
